School of Engineering
Showing 501-595 of 595 Results
-
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Sindy Tang
Associate Professor of Mechanical Engineering, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Radiology and of Bioengineering
Current Research and Scholarly InterestsThe long-term goal of Dr. Tang's research program is to harness mass transport in microfluidic systems to accelerate precision medicine and material design for a future with better health and environmental sustainability.
Current research areas include: (I) Physics of droplets in microfluidic systems, (II) Interfacial mass transport and self-assembly, and (III) Applications in food allergy, single-cell wound repair, and the bottom-up construction of synthetic cell and tissues in close collaboration with clinicians and biochemists at the Stanford School of Medicine, UCSF, and University of Michigan.
For details see https://web.stanford.edu/group/tanglab/ -
Hawa Racine Thiam
Assistant Professor of Bioengineering and of Microbiology and Immunology
Current Research and Scholarly InterestsCellular Biophysical Mechanisms of Innate Immune Cells Functions
-
Ross Daniel Venook
Senior Lecturer of Bioengineering
BioRoss is a Senior Lecturer in the Bioengineering department and he is the Associate Director for Engineering at the Stanford Byers Center for Biodesign.
Ross primarily co-leads undergraduate laboratory courses at Stanford—an instrumentation lab (BIOE123) and an open-ended capstone design lab sequence (BIOE141A/B)—and he supports other courses and runs hands-on workshops in the areas of prototyping and systems engineering related to medical device innovation. He enjoys the unique challenges and constraints offered by biomedical engineering projects, and he delights in the opportunity for collaborative learning in a problem-solving environment.
An Electrical Engineer by training (Stanford BS, MS, PhD), Ross’ graduate work focused on building and applying new types of MRI hardware for interventional and device-related uses. Following a Biodesign Innovation fellowship, Ross helped to start the MRI safety program at Boston Scientific Neuromodulation, where he worked for 15 years to enable safe MRI access for patients with implanted medical devices--including collaboration across the MRI safety community to create and improve international standards. -
Bo Wang
Assistant Professor of Bioengineering
Current Research and Scholarly InterestsResearch interests:
(1) Systems biology of whole-body regeneration
(2) Cell type evolution through the lens of single-cell multiomic sequencing analysis
(3) Quantitative biology of brain regeneration
(4) Regeneration of animal-algal photosymbiotic systems -
Lara Weed
Ph.D. Student in Bioengineering, admitted Autumn 2020
Current Research and Scholarly InterestsMy mission is to characterize and optimize human health, rehabilitation, and performance using physiological and biomechanical signals from wearable sensors.
-
Wendy Wenderski
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsMolecular mechanisms of chromatin remodeling by the BAF complex.
-
Rahel Woldeyes
Affiliate, Program-Chiu, W.
BioThe goal of my current research is to use high-resolution imaging techniques to interrogate outstanding questions in cardiac cell biology, with a focus on the signaling pathways that trigger heart muscle contraction. I currently use cryo-electron tomography-based imaging approaches to connect the molecular and cellular scales of biology and accelerate our understanding of human health and disease.
-
Joseph Woo, MD, FACS, FACC, FAHA
Norman E. Shumway Professor, Professor of Cardiothoracic Surgery and, by courtesy, of Bioengineering
BioDr. Woo is a board-certified, fellowship-trained cardiothoracic surgeon, cardiovascular surgeon, and transplant surgeon with Stanford Health Care. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery and associate director of the Stanford Cardiovascular Institute. He is also the Norman E. Shumway Professor of Cardiothoracic Surgery and professor, by courtesy, in the Department of Bioengineering.
Dr. Woo is a nationally recognized surgeon, innovator, researcher, and educator in cardiothoracic surgery. He focuses on complex mitral and aortic valve repair, thoracic aortic surgery, heart and lung transplantation, and minimally invasive heart surgery. He was awarded the American Heart Association’s 2021 Clinical Research Prize for developing innovative and minimally invasive surgeries to repair and reconstruct heart valves.
In 2022, Dr. Woo and his team at Stanford Health Care performed the first beating-heart transplant from a donation after circulatory death (DCD) donor and organ perfusion system. Keeping a donor heart pumping while it’s transported to the recipient and then implanting the heart while it’s beating minimizes organ damage. This groundbreaking new procedure is expected to increase the number of hearts available for transplant while improving health outcomes.
As a physician-scientist, Dr. Woo has served as principal investigator on multiple studies funded by National Institutes of Health (NIH) grants. One explored an innovative therapy to stimulate vascular (blood-carrying) stem cells in the bone marrow and direct them to the heart to grow new blood vessels and improve blood flow to damaged heart muscle.
Dr. Woo has also been the primary investigator for clinical trials involving the administration of stem cells during coronary artery bypass grafting (CABG) and left ventricular assist device (LVAD) implantation. In addition, Dr. Woo has served as primary investigator for multiple clinical device trials. He has filed for and holds patents for several heart-related medical devices and surgical techniques.
Dr. Woo has co-authored more than 450 articles in peer-reviewed journals and has served as a reviewer for many of them, including the Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, and Circulation. He has also presented his research and performed live surgery demonstrations both nationally and internationally.
Dr. Woo serves as vice president of the American Association for Thoracic Surgery (AATS) and past president of the AATS Cardiac Surgery Biology Club. He is a fellow of the American College of Surgeons, American College of Cardiology, and American Heart Association. He is a member of many other professional societies, including the World Society of Cardiovascular and Thoracic Surgeons and International Society for Heart Research. He also serves on the leadership committee of the American Heart Association’s Council on Cardiovascular Surgery and Anesthesia. -
Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.
-
Yunzhi Peter Yang
Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering
Current Research and Scholarly InterestsYang lab's research interests are in the areas of bio-inspired biomaterials, medical devices, and 3D printing approaches for re-creating a suitable microenvironment for cell growth and tissue regeneration for musculoskeletal disease diagnosis and treatment, including multiple tissue healing such as rotator cuff injury, orthopedic diseases such as osteoporosis and osteonecrosis, and orthopedic traumas such as massive bone and muscle injuries.
-
Paul Yock, MD
Martha Meier Weiland Professor in the School of Medicine and Professor of Bioengineering, Emeritus
Current Research and Scholarly InterestsHealth technology innovation using the Biodesign process: a systematic approach to the design of biomedical technologies based on detailed clinical and economic needs characterization. New approaches for interdisciplinary training of health technology innovators, including processes for identifying value opportunities in creating new technology-based approaches to health care.
-
Jeongwoong Yoon (Yoon)
Ph.D. Student in Bioengineering, admitted Autumn 2023
BioMy previous research in Japan focused on the development of genetic tools for marine bivalves. Inspired by the experience, I am seeking to find efficient and universally applicable methods to study non-model organisms that lack research infrastructure. As a biologist, I am most excited about the evolution of reproduction, everything from gametogenesis to reproductive behavior.
-
Xianfeng Zeng
Postdoctoral Scholar, Bioengineering
BioPh.D. in Chemistry, Princeton University (2023)
B.Sc. in Chemistry, Tsinghua University (2017)
